Transaction DateRecipientSharesTypePriceValue
20th October 2020Geoff Pardo3,685,358Conversion of derivative$0.00
20th October 2020Geoff Pardo233,333Open or private purchase$18.00$4,199,994.00
20th October 2020Bakker Juliet Tammenoms233,333Open or private purchase$18.00$4,199,994.00
20th October 2020Bakker Juliet Tammenoms3,685,358Conversion of derivative$0.00
5th October 2020Raymond W Cohen5,000Grant/award etc.$0.00
18th September 2020Bakker Juliet Tammenoms9,167Open or private sale$42.67$391,119.22
10th September 2020Michael H Carrel10,000Bona fide gift$0.00
2nd September 2020Alfred J Jr Ford35,000Exercise of derivative$1.42$49,700.00
2nd September 2020Alfred J Jr Ford23,743Open or private sale$40.41$959,364.41
2nd September 2020Alfred J Jr Ford11,031Open or private sale$39.84$439,526.89
Axonics Modulation Technologies
Axonics Modulation Technologies logo

Axonics Modulation Technologies, Inc. operates as a medical technology company. The firm focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR) It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve.


Ticker: AXNX
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1603756
Employees: 302
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals